| 发明名称 |
Compuesto de indazol y uso farmacéutico del mismo |
| 摘要 |
The present invention can provide a cancer treatment drug containing, as an active ingredient, a substance selected from the group consisting of an indazole compound of the following formula (I), a pharmaceutically acceptable salt, a hydrate, a water adduct and a solvate: |
| 申请公布号 |
ES2564804(T3) |
申请公布日期 |
2016.03.29 |
| 申请号 |
ES20050710048T |
申请日期 |
2005.02.10 |
| 申请人 |
Mitsubishi Tanabe Pharma Corporation |
发明人 |
TAKEMIYA, Akihiro;NAKAJO, Masahiro;OSHIMA, Hisae;YANAGI, Tomotaka;MOCHIZUKI, Mami;NAKAMURA, Hideo |
| 分类号 |
C07D403/12;A61K31/437;A61K31/4439;A61K31/454;A61K31/496;A61P9/00;A61P35/00;C07D231/56;C07D401/12;C07D417/12;C07D471/04;C07D487/04;C07D491/04;C07D495/04 |
主分类号 |
C07D403/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
